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Abstract
Progression through the cell cycle in somatic
eukaryotic cells is regulated by variations in the levels
of cyclin proteins. These protein levels are in turn
regulated by cyclical oscillations in their mRNA levels.
We show here that regulation of RNA stability plays a
role in the mechanisms underlying cell cycle
progression. Both cyclin A and BI messages are
expressed at high levels in G2-M and at low levels in
early G1. The half-lives of their messages mirror this
pattern, long in G2-M (>8 h) and short in early G1 (1-2
h). However, there is evidence of specificity to these
changes, because the cyclin A message becomes
stable at the G1-S boundary, whereas the cyclin BI
message is unstable until later in S phase.
Furthermore, although cyclin BI mRNA levels are
lowered after irradiation because of enhanced
instability, cyclin A mRNA levels and message stability
are unaffected by irradiation. Additional evidence of
specificity was found in an analysis of cyclin E mRNA
stability, which remains constant through the cell
cycle, although the cyclin E message displays cell
cycle-dependent changes in expression. These studies
suggest that specific alterations in RNA stability are an
important component in regulating the expression of
cyclins A and BI and hence in controlling the cell
cycle.
Introduction
The cyclins are a family of proteins essential for progression
through the cell cycle, the levels of which were originally
found to oscillate with the cleavage cycle in marine inverte-
brate embryos (1). Two different cyclins, designated A and
Bi , are required for the transition from G2 into M; however,
cyclin A is also required for progression through S phase
(2-4), and the highest levels of both of these cyclins are
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found in G2-M. The level of cyclin A protein rises earlier in the
cell cycle and falls earlier than the level of cyclin Bi (5, 6).
These changes are reflected in the cyclical variation in mRNA
levels. In HeLa cells, the level of cyclin A message starts to
rise in late G1 , continues to rise in S phase, peaks in G2-M,
and falls in early G1 (6). However, the level of cyclin Bi
message does not rise until mid-to-late S phase, peaks in
G2-M, and falls in early G1 (5). These cyclins act by binding
to catalytic subunits known as cyclin-dependent kinases,
and this binding is obligatory for the activation of these
kinases. Thus, the levels of cyclins control the activity of the
kinases that drive the cell cycle. In cycling mammalian cells,
the levels of the cyclin proteins mirror that of their mRNAs.
Thus, regulation of cyclin A and Bi mRNAs is critical to the
regulation of cell cycle progression.
Evidence suggests that the regulation of cyclin Bi mRNA
through the cell cycle is mediated both transcriptionally (7-9)
and posttranscnptionally (10). We found previously that a
construct containing a luciferase reporter gene downstream
of the cyclin Bi promoter showed a 3-4-fold variation in
luciferase activity through the cell cycle (8), but this is insuf-
ficient to explain the marked change (50-1 00-fold) in mRNA
levels seen between G1 and G2-M. In another report (10), we
showed that the cyclin Bi message was 5-1 0-fold more
stable in G2-M than in G1 . In the same report, we also found
that the stability of the cyclin Bi mRNA decreased after
exposure of the cells to ionizing radiation, contributing to the
suppression in cyclin Bi mRNA expression in these cells
following radiation (11 , 12).
In the current report, we investigated the contribution that
stability of the cyclin A and E messages plays in regulating
their variation through the cell cycle. Changes in transcription
play a role in the oscillation of cyclins A and E mRNA levels
(1 3-16). However, we find that changes in cyclin A mRNA
stability occur through the cell cycle that correlate with the
variation in steady-state levels, suggesting that this, also, is
important in controlling levels.
Results
Cyclins A, BI, and E mRNA Expression through the Cell
Cycle. The pattern of expression of cyclins A, Bi , and E was
followed as synchronized HeLa cells progressed through the
cell cycle following release from a G1-S block (see “Materials
and Methods”). Northern blots hybridized with either cyclins
A, Bi , or E probes are shown in Fig. 1 , and the results of
densitometric analysis and the flow cytometry are shown in
Fig. 2. All blots were also probed for the rpL32 mRNA (17),
which encodes a ribosomal protein and is a message, the
level of which does not vary through the cell cycle. The
hybridization to this probe served as a loading control, and all
of the signals were normalized to it. As expected, each of
these messages has a specific pattern of expression. The
level of cyclin Bi mRNA was low in G1 and peaked in G2-M.
The level of cyclin A mRNA was also low in G1 , but it rose0 3 5 7 9 11 1315 1719 21 24 26 Hours
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Fig. 1. Cyclins A, Bi , and E mANA variation through the cell cycle. HeLa
cells were synchronized at the G1-S border using a double thyrnidine/
aphidicolin block (see “Materials and Methods”) and released. At regular
intervals, samples were taken for both ANA harvesting and flow analysis.
Four different formaldehyde agarose gels were loaded identically with
RNA from this experiment (15 ￿g of ANNIane). Northern blotting was
performed, and each membrane was hybridized with a cDNA probe for
cyclin A, Bi , or E. Each blot was simuitaneously hybridized with a probe
for the rpL32 mANA, which does not vary significantly with the cell cycle,
making it useful as a loading control. Only the rpL32 panel for the cyclin
E membrane is shown in this figure, although it was done for all three.
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slightly ahead of the cyclin Bi message and fell slightly
earlier. There are three known cyclin A transcripts that differ
only in their 3’ untranslated regions, a major 2.7-kb band and
two minor bands of 1.8 and 2.5 kb (13). In our blots, we
detected a weak, diffuse 1.8-kb species and a prominent
larger band, which is the sum of the 2.5 and 2.7 bands and
was not resolved into its two components on these gels.
Cyclin E mRNA also varied through the cycle, but to a mod-
est extent (4-5-fold). The level of cyclin E mRNA was high at
the G1-S boundary, fell in S phase, remained low through
G2-M, and rose again in G1 , similar to what had been re-
ported previously (18). Thus, each of these cyclin mRNAs
showed the expected, distinctive patterns of cell cycle var-
iation.
Measurement of mRNA Stability through the Cell Cy-
cle. To measure the stability of cyclins throughout the cycle,
we used actinomycin D to inhibit transcription. We synchro-
nized cells in different phases of the cycle, then added the
drug at 4-5 h after release from aphidicolin when the cells
were in S phase, at 9-1 1 h when the cells were in G2-M, or
at 15-1 8 h when the cells were in early G1 . The addition of
actinomycin D effectively blocked cell cycle progression, as
shown by flow cytometry performed on samples at the be-
ginning and end of each cell cycle experiment (Table 1). To
obtain a population blocked at the G1-S boundary, cells were
arrested using mimosine, as described in “Materials and
Methods.” Mimosine is a plant amino acid that blocks cells at
the G1-S border prior to the block that results from aphidi-
cohn (1 9). It also blocks cells in S phase by inhibiting replicon
initiation (20), but because we added it to synchronized cells
11-12 h after release from a G1-S block, by which time they
Fig. 2. Quantitation of cyclins A, Bi , and E mANA variation through the
cell cycle. The Northem blots shown in Fig. 1 were scanned and quanti-
tated. Relative mRNA levels (ratio of the cyclmn to rpL32 intensity) are
plotted as a function of time after release from G1-S block. In A, variations
in cyclins A, Bi , and E mRNAs were plotted versus time. In B, the
percentages of cells in G1 or G2-M are plotted versus time after release
from G1-S block.
Table 1 Cell cycle distributions during actinomycin D experiments
Actinomycin D (10 ￿g/m￿ was added at various times following release
from a thymidine/aphidicolin block (early G1, 5, or G2 phase) or to mi-
mosine-arrested cells Qate G1) to obtain cells in different phases of the
cycle as described in the “Materials and Methods.” The distribution of
cells (percentage in G1 , S. or G2-M) at the time of actinomycmn D admin-
istration (Start) and at last timepoint collected in each experiment (End) are
shown. X(G2) refers to an experiment In which actmnomycin D was added
14 h after S phase irradiation when the cells were blocked in G2.
Cyclmn A Cyclin E
G1 S G2-M G1 S G2-M
Late G1
Start 88 6 6 88 6 6
End 83 12 6 83 12 6
S phase
Start 2 91 6 3 87 9
End 2 92 5 4 87 8
G2-M
Start 22 16 63
End 32 12 56
Early G1
Start 87 8 4 69 26 5
End 83 13 4 69 26 5
X(G2)
Start 5 4 91
End 10 4 86w
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Fig. 3. Cyclin A mANA stability in
different phases of the cell cycle.
Cells were released from a thymi-
dine/aphidicolin G1-S block. Acti-
nomycin D (10 j.￿g/rnl) was added
5, 11 , or 16 h following release to
arrest the cells in S phase, G2-M,
and early G1 , respectively. To as-
sess the decay in late G1 , actino-
mycin D was added to mimosine-
arrested cells. RNA was harvested
at the indicated times, and the re-
sultant Northern blots are shown.
The percentages of cells in G1 , S
phase, or G2-M during each exper-
irnent are shown in Table 1 . All
membranes were simultaneously
hybridized with cDNA probes for
cyclin A and rpL32, which serves
as a loading control. All mem-
branes were stripped and rep-
robed for c-myc to demonstrate
the efficacy of actinornycin D in in-
hibiting transcription.
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had progressed past S phase, we obtained a population of
cells blocked just prior to S phase.
Samples were taken for RNA extraction at regular intervals
following actinomycin D administration, and Northern blots
were performed and probed for either cyclin A, Bi , or E. The
membranes were simultaneously probed for rpL32 mRNA,
which has a half-life of of >25 h (data not shown) and served
as a loading control. To confirm that the actinomycin D had
actually inhibited transcription, all membranes were stripped
and rehybridized with a probe for c-myc, which showed the
expected rapid decay in all cases. Thus, these experiments
allowed a determination of mRNA half-lives for cyclins A and
E from cells arrested in late G1, S phase, and G2-M.
Cyclin A mRNA Stability through the Cell Cycle. Fig. 3
shows the Northern blots used to measure cyclin A mRNA
stability after the administration of actinomycin D in different
phases of the cell cycle. Quantitation of the Northern blots
(Fig. 4) showed that in all four cases, the mRNA underwent a
first-order exponential decay. The half-lives of the cyclin A
mRNA in different phases of the cycle were calculated from
these decay curves (Table 2). Similar results were obtained in
repeat experiments. In S and G2-M phases when both cyclinTime (hours)
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Fig. 4. Quantitation of cyclmn A mANA stability in different phases of the
cell cycle. The Northern blots shown in Fig. 3 were scanned and quanti-
tated. Relative mANA levels (ratio of the cyclin A to rpL32 intensity) are
plotted as a function of time after release from G1-S block. All curves fit
first-order exponential decays with the following half-lives. Early G1, 1.6 h
(95% confidence interval, 1.3-2.2 h, r = 0.96); Late G1, 11.6 h (95%
confidence interval, 7.0-30 h, r = 0.80); S, 7.8 h (95% confidence interval,
5.5-13.6 h, r = 0.92); G2-M, 8.1 h (95% confidence interval, 6.1-12.1 h,
r = 0.97).
A and Bi levels are rising, the half-lives are relatively long, 8
and 8 h, and 8 and 13 h, respectively. In early G1 when both
have low levels, the half-lives of both cyclins A and Bi were
relatively short, 1.6 and 1.1 h, respectively. Although cyclin A
mRNA stability was identical to that of cyclin Bi mRNA in
early G1 , S phase, and G2-M, it was very different at the G1-S
border. The level of cyclin Bi mRNA is low both in early and
late G1 , and its half-life is short at both times (10). In contrast,
the half-life of the cyclin A mRNA, although short in early G1,
is long in late G1 , which is consistent with the rise in message
level seen at the G1-S boundary. The pattern of cyclin A
mRNA stability mirrors its fluctuation in level through the cell
cycle and is distinct from that of cyclin Bi . These patterns
reflect the distinctive patterns of mRNA levels of each
through the cell cycle. They also reflect the distinct functions
of these two cyclins, with cyclin A required both in S phase
and G2-M but Bi only needed in G2-M. Thus, alterations in
cyclin A mRNA stability appear to contribute to the variations
seen in its level.
Half-Life of Cyclin A after Irradiation. Because we found
previously that the cyclin Bi mRNA was destabilized after
ionizing radiation (10), we determined the effect of irradiation
on cyclin A mRNA stability. The cells were exposed to 10 Gy
3 h after release from a G1-S block, when most of the cells
were in S phase (15% G1, 80% S phase, and 5% G2-M).
Actinomycin D was added 14 h after irradiation, whereas the
cells were blocked in the radiation-induced G2 arrest (see
Table 1 for cell cycle distributions). Analysis of the Northern
blot (Figs. 5 and 6; Table 3) showed that the half-life for the
cyclin A mRNA was 8.8 h during the G2 block. In contrast,
when the same membrane was probed for cyclin Bi , the
half-life was 2.2 h. Similar results were obtained in repeat
experiments. Thus, the cyclin A and Bi messages behave
very differently after radiation in these cells.
Table 2 Summary of cyclin mANA half-lives through the cell cycle
The half-lives calculated from the data in Fig. 4 and 8 are summarized.
Also included for comparison are data for cyclin Bi mRNA half-lives not
shown in this paper but taken from previous work (1 0). The numbers in
parentheses indicate half-life measurements in cells without actinomycin
D at times when the mANA was declining rapidly (see Fig. 9).
Cyclin Early G1 Late G1 S G2-M
A 1.6h(1.4) 12 8 8
Bi 1.1-2.3(1.2) 1.8 8 13
E 3.7 2.6(3.3) 3.1
Cyclin E mRNA Stability through the Cell Cycle. In con-
trast to cyclins A and B1 mRNAs that show dramatic
changes in stability through the cell cycle, the stability of
cyclin E mRNA did not change through the cell cycle. The
half-life of cyclin E mRNA was 3.7, 2.6, and 3.1 in early G1,
late G1 , and S phases, respectively, (Figs. 7 and 8) with
repeat experiments giving similar values. Thus, in contrast to
cyclin A, cyclin E mRNA stability did not vary with the cell
cycle.
Alternate Measurements of Cyclin Half-Lives. We have
attempted to independently confirm the half-life measure-
ments in the absence of actinomycin D. ANA pulse chase
experiments did not succeed because of the relatively low
abundance of the messages. We obtained some confirma-
tion by calculating the half-lives of the messages at the time
in the cycle when their levels were rapidly falling. Cyclin A
and Bi levels drop rapidly during the transition from M to G1.
Because transcriptional activity is considerably lower for
both these messages at this time, this calculation approxi-
mates the complete transcriptional blockade by actinomycin
D. Because some transcription is occurring, this method may
underestimate the rapidity of the decay. However, the cal-
culations made in this way conform closely to the numbers
obtained using actinomycin D. For example, the level of the
cyclin A mRNA fell during the interval from 9-13 h following
release from a G1-S block as cells moved from G2-M through
to G1 (Fig. 2). When plotted on a semilog scale in Fig. 9, these
points fit a curve showing a first-order exponential decay
with a half-life of 1 .4 h, in good agreement with the half-life of
1 .6 h obtained above. Because cyclin E levels fall rapidly in
S phase, the points at this time were similarly plotted, leading
to a calculated half-life of 3.3 h (Fig. 9), again close to the
value of 2.6 obtained with actinomycin D blockade.
Discussion
We found that the stability of cyclin A mRNA in HeLa cells
varied throughout the cell cycle with a long half-life at the
G1-S boundary and during S phase and G2-M and a short
half-life in early G1 . This pattern of stability parallels the
oscillations in cyclin A mRNA levels through the cell cycle.
Cyclin A mRNA in HeLa cells starts to accumulate in early S
phase and peaks in G2-M, falling to its lowest levels in G1
with a similar pattern found in human diploid fibroblasts (21)
and rat hepatocytes (4). Because cyclin A is required for
passage through S phase as well as in the G2-M transition
(2-4), the increased stability of its mRNA in late G1 would
allow for the subsequent accumulation of its mRNA and0 1 2 3456
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Fig. 5. Cyclins A and Bi mRNA stability
following irradiation of HeLa cells in S
phase. Cells were synchronized as de-
scribed. Three h after release from the
G1 -S border, cells were irradiated with 10
Gy. Actinomycin 0 was added 14 h after
irradiation when cells were blocked in G2
(indicated as time 0). Twenty ￿g of total
RNA were loaded in each lane, and North-
em blotting was performed with cyclins A,
Bi , and rpL 32 as probes. Percentages of
cells in G1, S phase, and G2-M are shown
inTable 1.
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Fig. 6. Quantitation of cyclins A and Bi mANA stability following irradi-
ation of HeLa cells in S phase. Northern blots shown in Fig. 5 were
scanned and quantitated. Relative cyclin mANA levels (ratio of cyclin to
rpL32 intensities) are plotted versus time after the addition of actinomycin
D. Cyclins A and Bi mANAs showed exponential decays with half-lives of
8.8 h (95% confidence interval, 5.8-18.5 h, r = 0.86), and 2.2 h (95%
confidence interval 1.7-3.1 h, r = 0.95), respectively.
protein in S phase. Cyclin E mRNA stability did not vary in the
different phases of the cell cycle. These results suggest that
posttranscriptional regulation plays an important role in reg-
ulating cyclin A mRNA levels and thus contributes to regu-
lation of cell cycle progression.
In contrast to cyclin A, the level of the cyclin Bi mRNA,
in which the protein is only required for the G2-M transition
and not in S phase, is still low at the G1-S border and does
not start to rise until late S phase, 2-3 h after the cyclin A
message. Consistent with this pattern, we found previ-
ously that the cyclin Bi mRNA is stable in S phase and
G2-M but not in early or late G1 (1 0). The pattern of change
in stability of cyclin A mRNA is thus clearly distinct from
that of cyclin Bi . Both cyclins are highly unstable in early
G1, but as the cells progress through G1, cyclin A mRNA
becomes stable prior to the increased stability seen in
cyclin Bi . Furthermore, cyclin A mRNA is not destabilized
after radiation, in contrast to cyclin Bi mRNA, consistent
with our finding that following irradiation, cyclin Bi mRNA,
but not cyclin A mRNA, is suppressed (12). This indicates
Table 3 Cyclin mANA half-lives after radiation
The experiment was performed as described in Fig. 5. mRNA half-lives
after radiation were calculated from Fig. 6. The numbers in the control
column are half-lives for cells in G2-M that had not been irradiated.
Cyclin Control After radiation
A 8 9
Bi 13 2
that there is considerable specificity to the pattern of
stability of these cyclin messages, both through the cell
cycle and after radiation. Although the mechanism under-
lying such differential stability is unknown at present, this
result implies that the Cis-acting sequences on the cyclin
A and Bi messages are responsible for cell cycle-depen-
dent instability, and that proteins may bind to them in a cell
cycle-dependent manner.
It is important to note that these studies have been carried
out in HeLa cells, which are a transformed cell line derived
from a cervical carcinoma. Whether one can extrapolate
these findings to other cell lines, especially untransformed
ones, remains to be seen. Actinomycin D was used to block
transcription for many of the measurements reported here.
Transcriptional inhibitors, paradoxically, can retard the de-
cay of some mRNAs (22, 23); therefore, half-life determina-
tions using actinomycin D must be interpreted with caution.
However, our calculations of the half-lives of the cyclins A
and E mRNAs using actinomycin D agree almost exactly with
our measurements in early G1 and at the G1-S transition,
respectively, without any drug (Fig. 9); therefore, at least in
these specific situations, actinomycin D does not lead to a
spurious result.
Transcriptional regulation is also important in the regula-
tion of cyclin A mRNA levels. In synchronized NIH 3T3 cells,
the cyclin A promoter was found to be repressed in G1 and
activated as cells reach the G1-S border (13). Similarly, we
found the cyclin Bi promoter to be transcriptionally activated
in a cell cycle-specific manner (8). Therefore, both transcrip-
tional and posttranscriptional mechanisms act in concert to
modulate the levels of cyclin A and Bi messages through the
cell cycle. Transcriptional control is also important for regu-
lating cyclin E mRNA levels through the cell cycle. The cyclin
E promoter has been cloned by several groups and has been
found to contain E2F binding sites, which are required for cell
cycle-dependent transcription (1 4-i 6).Late Gi
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Fig. 7. Cyclin E mANA stability myc ￿ different phases of the cell cy-
cle. Cells were released from a
thyrnidine/aphidicolin G1-S block.
Actinomycin D (10 ￿g/ml) was
added 4.5 h or 15 h following re-
lease to arrest the cells in S phase
and early G1, respectively. To as-
rpL32 sess the decay in late G1, actino-
rnycin D was added to mimosine-
arrested cells. ANA was harvested
at the indicated times, and the re-
sultant NOrthern blots are shown.
The percentages of cells in G1, S
phase, or G2-M during each exper-
iment are shown in Table 1. All
membranes were simultaneously
hybridized with cDNA probes for
rpL32, which serves as a loading
control, and cyclin E. All mem-
branes were stripped and rep-
robed for c-rnyc to demonstrate
the efficacy of actinomycin D in in-
hibiting transcription.
Other groups have measured the stability of cyclin A mes-
sages in various cell lines; however, these studies were done
on asynchronous cells (24, 25). To our knowledge, our study
is the first to examine the stability of cyclin A mRNA in
different phases of the cell cycle. Our results suggest that
regulation of mRNA stability of cyclin A and also Bi is im-
portant for cell cycle control, whereas cyclin E is controlled
only through transcriptional means. It has been suggested
that in Rat 1A cells, cyclin E mRNA is more stable in serum-
stimulated cells than in quiescent, G0-arrested cells (26);
however, quantitative analysis of those Northern blots sug-
gests that the half-lives in these two situations are not very
different. Our results indicate that alterations in stability do
not influence the cyclical pattern of cyclin E mRNA levels
through the HeLa cell cycle.
Materials and Methods
Cell Culture, Synchronization, and Irradiation. HeLa cells were grown
in DMEM supplemented with 5% fetal bovine serum, 100 units/mI peni-
cillin, and 100 mg/mI streptomycin and maintained at 37#{176}C in a humidified
atmosphere of 5% CO2. To synchronize them at the G1-S boundary, we
used a thymidine/aphidicolin block similar to that described previously
(10). Two m￿ thymidine (Sigma Chemical Co., St. Louis, MO) were added
to exponentially growing cells; 12 h later, the thymidine was washed out,
and media containing 2.4 x iO￿ M thymidine and deoxycytidine (Sigma)
were added. After 16-18 h, 1 ￿g/ml aphidicolin (Sigma) was added, and
12 h later, the cells were released from the aphidicolin block by washing
the cells twice with media. To arrest cells in late G1 , we used an additional
block following thyrnidine/aphidicolin. Eleven to 12 h after release from the
aphidicolin block, mimosine (Sigma) was added to a final concentration of
400 ￿M. After 16 h of incubation in rnimosine, actinornycin D was added
for ANA stability studies.
Actinomycin D Studies, RNA Extraction, and Northern Blot Analy-
sis. For actinornycin D studies, the drug was added at a final concen-
tration of 10 ￿g/ml to replicate dishes. Total ANA was isolated using
RNazol (Cinna/Biotec, Houston, TX) as described elsewhere (27). Five to
15 ￿g of ANA were denatured with formaldehyde and formamide and run
on a 0.9% agarose gel containing formaldehyde. ANA was transferred by
capillary action in 20x SSC (1 x SSC is 0.15 M NaCI, 0.015 M sodium
citrate, pH 7) to a Duralon UV (Stratagene, La Jolla, CA) membrane and UV
cross-linked prior to hybridization. Labeling of radioactive probes was
performed using r2P]dCTP and the random primer method. Hybridization
was carried out at 65#{176}C, after which membranes were washed to a
stringency of 0.5x SSC, 0.1% SDS at 65#{176}C. Autoradiography was carried
out at - 80#{176}C with intensifying screens. Fragments used for probes were
excised from plasmids containing cDNAs for cyclin E (a gift from C. V.Time (hours)
0 2 4 6 8
Time (hours)
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Fig. 8. Quantitation of cyclin E mANA stability in different phases of the
cell cycle. The Northern blots shown in Fig. 7 were scanned and quanti-
tated. Relative mRNA levels (ratio of the cyclmn to rpL32 intensity) are
plotted as a function of time after release from G1-S block. Early G1, late
G1 , and S-phase curves fit first-order exponential decays with the follow-
ing half-lives. Early G1, 3.6 h (95% confidence interval, 2.4-7.8 h, r =
0.86); Late Gi, 2.6 h(95% confidence interval, 2.3-3.0 h, r = 0.99); S, 3.1 h
(95% confidence interval, 2.4-4.1 h, r = 0.97).
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Fig. 9. Estimate of cyclmns A and E mRNA half-lives. Data from Fig. 2 are
replotted on a semilog graph. The pomntsfor cyclmns A and E mANAs were
taken when the levels were declining rapidly. For cyclmn A message, this
was as cells were entering G1 (times of 9, 11 , and 13 h following release
from G1-S). For cyclmn E mANA, this was at the G1-S transition (times of 0,
3, 5, and 7 h after release from G1-S). Both cyclins A and E mANA decays
fit a first-order exponential decay with half-lives of 1.4 h (r = 0.99) and
3.3 h (r = 0.94), respectively.
Dang, Johns Hopkins University School of Medicine, Baftimore, MD),
cyclins A and Bi (gifts from T. Hunter, Salk Institute, San Diego, CA), and
myc and rpL32 (gifts from W. M-F. Lee, University of Pennsylvania School
of Medicine, Philadelphia, PA).
Flow Cytometry. Immediately after harvesting, cells were frozen in
liquid nitrogen in 1 ml of 40 m￿ citrate buffer and 5% DMSO and stored
at -80#{176}C until analysis. At this time, the cells were thawed and stained
with propidium iodide as described elsewhere (28). Flow analysis was
performed on the Becton Dickinson FACSCan flow cytometer, and the
data were interpreted using the CeIIFIT cell cycle analysis program (ver-
sion 2.01 .2). At least 5000 cells were analyzed for each sample.
Optical Densltometry and StatisticalAnalysis. Optical densitornetry
was performed using an LKB Uitroscan XL laser densitometer equipped
with an LKB 2400 Gelscan XC software package, version 1.20 (LKB
Produkter, Bromma, Sweden). Unear regression was performed using
Microsoft Excel, version 4.0. Curve fitting was performed with the corn-
mercially available software Cricketgraph Ill, version 1.5.1 (Computer
Associates). Confidence intervals (95%) of half-lives and correlation co-
efficients (r values) were calculated using the statistical package in
Microsoft Excel 4.0.
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